EXTENSION AGREEMENTExtension Agreement • January 3rd, 2023 • Acer Therapeutics Inc. • Pharmaceutical preparations
This Extension Agreement (this “Extension Agreement”) dated as of December 30, 2022, is among Acer Therapeutics Inc., a Delaware corporation (“Borrower”), MAM Aardvark, LLC, not individually, but solely in its capacity as administrative and collateral agent for the Lenders (the “Agent”) and the Lenders party hereto.
